Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
NHS Bristol, North Somerset and South Gloucestershire Integrated Care Board have awarded a time limited contract for the provision of 8 P2 Pathway Discharge to Assess Beds to Brunelcare Ltd under urgent circumstances. These beds will be delivered at Orchard Grove operated by Brunelcare Ltd.
The system is facing an immediate and unplanned capacity shortfall from April 2026 and creates a direct and imminent risk to patient safety and system flow, which could not reasonably have been fully mitigated through earlier procurement action given the reliance on transformation programmes that were, at the time, expected to reduce demand within the existing contracted capacity.
Pathway 2 (P2) beds form part of the Discharge to Assess (D2A) model and are intended for individuals who are medically optimised for discharge from acute hospital settings but require a short period of ongoing recovery, rehabilitation, and/or assessment prior to returning home or moving to a more appropriate long-term care setting.
P2 beds are typically provided within community-based rehabilitation units, step-down facilities, or care home environments and focus on enabling individuals to regain independence, reduce care needs where possible, and support safe discharge through multidisciplinary input, including therapy and clinical oversight where required.
The service is VAT‑exempt, and all contract values stated are excluding VAT
| Supplier | Identifier | Award Value | Lots Won | Cross-References |
|---|---|---|---|---|
| Brunelcare Ltd | Charity Commission: 201555 Companies House: 00601847 | £727,619 | 1 lot Lot 1 | - |
Taken from this notice, not from Companies House. Check the original notice — details change and are not updated here.
This procurement was divided into 1 lots, each awarded separately. 1 bids were received in total.
| Lot | Value | Bids Received | Awarded To | Status |
|---|---|---|---|---|
| Lot 1 | £727,619 initial term | 1 single bid — no competition | active |
Weightings from the notice.
Changes the buyer published to this notice after it first appeared.
The contract period commenced on 1st April 2026 for an initial 18-month contract and an optional 12-month extension.
The total expected value of the contract for the initial 18-month contract term is £2,189,295.77 excluding VAT The optional 12-month extension expected value of the contract is £1,463,355.18 excluding VAT. Therefore, the full expected lifetime contract value (18-month + optional 12-month extension) is £ 3,652,650.95 excluding VAT
This is a Provider Selection Regime (PSR) confirmation of contract award notice. This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 and The Procurement Act 2023 do not apply to this award. This contract has now been formally awarded using direct award process C.